GLUC.US Glucose Health Inc
- Market cap
- USD 8.48M
- P/E
- -
- P/B
- -
- ROE
- -1,275.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is GLUC.US undervalued?
Graham numberThe Graham number of Glucose Health Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Glucose Health Inc fundamental analysis
No fundamental analysis for Glucose Health Inc yet.
Glucose Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Glucose Health Inc
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Be…
Full company profileGlucose Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Glucose Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 313K | 105K | 198K | 291K | 481K | 954K | 1.07M | 535K | 384K | 341K | 197K |
| Gross Profit | 19.2K | 45.1K | 52.8K | 52.7K | 174K | 410K | 457K | 216K | 75.5K | 119K | -30.2K |
| Operating Income | -86.6K | -59.8K | -23.5K | -230K | -564K | -336K | -562K | -422K | -307K | -200K | -939K |
| EBITDA | -86.6K | 44.1K | -23.4K | -201K | -564K | -336K | -562K | -422K | -305K | -197K | -937K |
| Net Income | -410K | 24.5K | -47.1K | -246K | -581K | -339K | -562K | -422K | -316K | -231K | -939K |
| EPS | -0.15 | 0.01 | -0.01 | -0.03 | -0.05 | -0.03 | -0.04 | -0.02 | -0.02 | -0.01 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 33.1K | 26.9K | 89.2K | 220K | 345K | 1.16M | 598K | 399K | 322K | 175K | 247K |
| Total Liabilities | 529K | 459K | 560K | 381K | 304K | 9.56K | 21.0K | 141K | 387K | 27.8K | 173K |
| Shareholders' Equity | -495K | -433K | -471K | -161K | 41.1K | 1.15M | 577K | 258K | -65.0K | 147K | 73.6K |
| Cash & Short-term Investments | 20.5K | 22.4K | 20.3K | 46.5K | 69.2K | 752K | 267K | 204K | 26.5K | 30.8K | 35.2K |
| Total Debt | 352K | 374K | 465K | 335K | 112K | - | - | - | 234K | - | 4.26K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -39.3K | -58.1K | -82.2K | -234K | -68.9K | -72.7K | -389K | -244K | -455K | -15.8K | -318K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 3.30K | 0.00 | 4.00 | 5.00 | 18.5K | 0.00 | 0.00 |
| Free Cash Flow | -39.3K | -58.1K | -82.2K | -234K | -72.2K | -72.7K | -389K | -244K | -474K | -15.8K | -318K |
| Ratios | |||||||||||
| ROE | - | - | - | - | -1,415.1% | -29.6% | -97.4% | -163.7% | - | -157.2% | -1,275.6% |
| ROA | -1,238.3% | 91.1% | -52.7% | -112.0% | -168.7% | -29.3% | -94.0% | -105.8% | -98.0% | -132.2% | -380.7% |
| Net Profit Margin | -131.0% | 23.5% | -23.8% | -84.5% | -121.0% | -35.5% | -52.4% | -78.9% | -82.3% | -67.7% | -476.0% |
| Debt to Equity | - | - | - | - | 2.73x | - | - | - | - | - | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Glucose Health Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | USD 18.8K | 0.00 | - |
| 2023 | USD 19.8K | 0.00 | - |
| 2022 | USD 95.8K | 0.01 | - |
| 2021 | USD 99.4K | 0.01 | - |
| 2020 | USD 49.6K | 0.00 | - |
| 2019 | USD 16.8K | 0.00 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:50 on Nov 17, 2014.
Who owns Glucose Health Inc
- Insiders 5.10%
- Institutions 0.00%
- Public & others 94.90%
- Shares outstanding 27.4M
- Free float 8.27M
Glucose Health Inc company profile
- Company name
- Glucose Health Inc
- Ticker
- GLUC.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- December
- Address
- 609 SW 8th Street, Bentonville, AR, United States, 72712
- Phone
- 479 802 3827
- Website
- glucosehealthinc.com
About Glucose Health Inc
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Glucose Health Inc management
3- Mr. John DuffyCEO & Director · born 1971
- Mr. Marc HatchCFO & COO
- Ms. Peggy KnightAdvisor of Marketing & Branding · born 1956